Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Study Phase : Approved FDF
Sponsor : Cosette Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Cosette Acquires Ambien® and Ambien CR® from Sanofi US
Details : Cosette Pharmaceuticals Acquires Ambien (Zolpidem Tartrate) Tablet from Sanofi US. It is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Product Name : Ambien
Product Type : Controlled Substance
Upfront Cash : Undisclosed
October 07, 2024
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Highest Development Status : Approved FDF
Sponsor : Cosette Pharma
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ambien-Generic (zolpidem tartrate) is a small molecule, GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator. It is indicated for the treatment of insomnia.
Product Name : Ambien-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
August 07, 2021
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : With this approval by Australia's TGA, ZolpiMist will be included on the Australian Register of Therapeutic Goods and will be able to be commercialized and supplied within Australia.
Product Name : Zolpimist
Product Type : Controlled Substance
Upfront Cash : Inapplicable
July 30, 2020
Lead Product(s) : Zolpidem Tartrate
Therapeutic Area : Sleep
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable